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ABSTRACT
Airway clearance techniques (ACTs) are recommended in cystic fibrosis (CF) to prevent accumulation
of secretions and lung infection. “Can exercise replace chest physiotherapy for people with CF?” is
one of the CF community’s top 10 research questions. We conducted an online survey of the CF
community to gather data on current ACT use, recommendations, reported adherence levels and
exercise strategies used. There were 488 respondents: 194 (40%) people with CF (pwCF), 141 (29%)
family and 153 (31%) healthcare professionals (HCPs) (mostly physiotherapists). Only 10/285 (4%) of
pwCF do no exercise at present and 163/303 (54%) already incorporate exercise into ACTs. ACTs
were omitted by 128/267 (48%) of pwCF when they exercised. Nearly all (110/129, 93%) of HCPs
currently recommend exercise to support ACTs. A trial replacing some or all ACTs with exercise, was
supported by 80/110 (73%) of HCPs, with an additional 9/110 (8%) willing to consider in selected
patients.
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INTRODUCTION
Cystic fibrosis (CF) is characterised by a failure of mucociliary clearance and accumulation of viscid
secretions in the airway, leading to recurrent infection. To mitigate this process, CF treatment
guidelines recommend the regular use of an airway clearance technique (ACT), with exercise as an
adjunct(1). In people with CF (pwCF), exercise such as running or cycling, increases ease of sputum
expectoration, minute ventilation and respiratory flow(2). A comparison of one ACT with treadmill
exercise showed that these approaches performed similarly over a single session(3). These studies
suggest that exercise might be a replacement rather than an adjunct to some or all of a patient’s ACT
programme.
In a recent patient engagement exercise, the James Lind Alliance (JLA) Priority Setting Partnership
(PSP) in CF, the patient and clinical community jointly identified the top 10 questions for clinical
research in CF(4). “Can exercise replace chest physiotherapy for people with CF?” was one of these
research priorities. Exercise also featured as a topic of importance in the US CF Foundation’s Insight
CF project(5). We conducted an online survey in order to understand further how the CF community
currently uses exercise to supplement or replace ACT, and to assess the acceptability to patients and
healthcare professionals (HCPs) of a clinical trial to investigate replacing ACT with exercise.
METHODS
This work was led by a steering group representative of the CF community (lay and professional) and
supported by the UK National Institute for Health Research (NIHR) under the title “James Lind CF2”.
An online questionnaire was co-produced using SurveyMonkeyTM to help us understand which ACTs
are currently undertaken by people with CF and recommended by HCPs, current levels of reported
adherence and exercise strategies used (See online supplement 1). The survey was designed to be
inclusive, with no minimum age or restrictions on location, and was open over 5 weeks in December
2018-January 2019. There were separate streams for lay and professional respondents to complete.
It was promoted via our TwitterTM account (@questionCF), professional networks, UK CF Trust, US CF
Foundation Community Voice group and the NIHR. The survey data were downloaded to Excel for
quantitative analysis (closed questions) and NVivo for thematic analysis (free text comments) in
order to generate topics which represented recurring themes.
RESULTS
There were 488 respondents, with 335 (69%) from the lay community. Of these 194 (58%) were
people with CF and 141 (42%) family of people with CF. Of the HCPs, 63% were physiotherapists.
The greatest number of respondents were from the UK (n = 220, 45%) followed by North America
(n=134, 28%). Median age of respondents with CF was 33 years (range 14-74 years) and median age
of those whose parents or family answered on their behalf was 8 years (range 1 – 33 years). Survey
respondent characteristics are summarised in appendix table 1. Not all respondents answered every
question so denominators will vary (supplement 2).
Figure 1a shows the type of exercise most popularly undertaken by people with CF and grading of
intensity using metabolic equivalent of tasks (METs)(6), with walking (moderate intensity) and
running (high intensity) the most popular. The majority of people with CF exercise 3-5 times a week
with only 10/285 (4%) of lay respondents reporting no exercise (figure 1b). Almost all (110/129,
93%) HCPs currently recommend exercise as a way of supporting ACTs and recommend all
intensities of exercise (figure 1c). A full list of the top 20 exercises with METs are in appendix table
2.
Figure 1. Current exercise habits and intensity in CF. a) The top five types of exercise currently
undertaken by people with CF as indicated by the survey respondents (n=266). Coded from free text
answers where respondents could give more than one exercise type. Corresponding exercise
intensity with metabolic equivalence values (METs) (6) shown for each type of exercise. Cut offs for
exercise intensity (in METs) were as follows: light = <3, moderate = 3-5.9, high = >6(6). b) Frequency
of exercise undertaken at present by survey respondents (n=285). Single response allowed per
respondent. c) Intensity of exercise believed to be beneficial by HCPs (n=110). Multiple responses
allowed per respondent.
People with CF do exercise for many reasons (figure 2a), with the most popular being for lung health
(204/279, 73%) followed by general health (185/279, 66%) and enjoyment (168/279, 60%). Only two
of 277 respondents felt that exercise does not help clear their lungs. Better sputum production
(184/275, 67%), better lung function (175/275, 64%) and “feeling better” (173/275, 63%) were the
top three ways that people with CF believe exercise is working to clear their lungs (figure 2b). Poor
health (161/266, 61%), time (38/266, 14%) and weather (15/266, 6%) were the top three factors
that stopped people with CF from exercising. Six percent (15/266) replied that nothing ever gets in
the way of exercise (figure 2c).
Only 35% of respondents with CF (98/284) reported using an App or tracker to monitor physical
activity and 68 reported the type of device used. Wearable devices were used by 85% of those who
told us what they used (58/68) and Apps by 15% (10/68). Of the wearable devices, FitbitTM was the
most popular (figure 2d).
Figure 2. Drivers behind exercise. a) Reasons why people with CF exercise (n=279). Multiple responses allowed per respondent. b) Effects of exercise
(n=275). Multiple responses allowed per respondent c) Factors that stop people with CF from exercising (n=266). ). Coded from free text answers where
respondents could give more than one reason. d) Current app/technology use to aid exercise in people with CF (n=284). Single response allowed per
respondent.
Time spent on ACTs varied among respondents, with, on average, people with CF spending 30mins-
one hour a day over two sessions (figure 3a and 3b) (range 0-3 hours a day over 0-5 sessions a day).
Over half of people with CF (163/303, 54%) already incorporate exercise into their ACTs and almost a
quarter (73/303, 24%) already do exercise alone for their ACT (figure 3c). Almost 60% (180/302) of
respondents admit to skipping their ACTs, with “life”, “how I feel” and “time” being the main
explanatory themes given for this.
Almost half (128/267, 48%) of all respondents may drop their prescribed ACT if they have exercised
(figure 3d) (including 49% (80/163) of those who incorporate exercise into their ACT). Nearly three
quarters (80/110 , 73%) of HCPs would support a trial of replacing some or all airway clearance
techniques with exercise, with an additional 8% (9/110) willing to consider supporting a trial in
selected patients (figure 3d). Online supplement 3 shows trial suggestions collected from the CF
community.
Figure 3. Current ACT practice and views on future trials. a) Average number of sessions spent daily
on ACT (n=302). Single response allowed per respondent. b) Average time spent daily on ACT
(n=301). Single response allowed per respondent. c) The use of exercise, ACT and combinations of
the two in survey respondents (n=303). Multiple responses allowed per respondent d) Numbers
reporting dropping an ACT session when they have exercised (n=267). Single response allowed per
respondent. e) Support for a trial of replacing ACT with exercise (n=110). Single response allowed
per respondent.
DISCUSSION
Here we have explored current exercise use in people with CF and the influence it has on their ACT
regimens. Most people with CF already incorporate exercise into their lives. Activity levels are
higher than the general population. Around 20% of the UK population are classed as “inactive”(7)
whereas only 4% of our CF population claimed to do no exercise. Almost half of people with CF
regularly omit their prescribed ACT if they have exercised. This level of adherence is consistent with
previous studies that have estimated adherence levels with CF physiotherapy to be 40-50%(8, 9) .
We found that most HCPs would support a trial replacing ACT with exercise. A recent Cochrane
review looking at exercise for CF found 15 studies assessing the effect of exercise on people with CF
but all included control groups who were not exercising rather than omitting any ACT (10). A
systematic review comparing current clinical trials with the JLA top 10 did find two trials that loosely
matched with “Can exercise replace physiotherapy?”(11). One is a feasibility study evaluating
whether those who adhere to an exercise programme can then drop their ACT(12). The other is a
crossover study looking at the effect of mucus clearance from exercise, ACT or sitting still(13). These
studies aim to enrol small numbers (17 and 25 patients respectively) and results are, as yet,
unpublished. A larger, adequately powered, multicentre trial is needed.
As with all anonymous online surveys, there are limitations. What people self-report and what they
actually do can be quite different. However, an advantage of anonymity is that it allows respondents
to be more honest without worry of repercussions. People with CF may be more conscious of things
they can do to improve their health or it may be that the subsection of the CF population taking part
in our survey are more interested in exercise, leading to response bias.
Many people with CF omit ACT if they have exercised. There is support amongst professionals for a
trial of replacing current ACT with exercise. The data presented here will allow us to design clinical
studies which will begin to answer the question of whether exercise can replace some ACT. Although
most of our respondents were from the UK and US over a quarter were from elsewhere in the world.
It is therefore reasonable to conclude that the themes and trends noted are applicable to the global
CF population.
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Appendix Table 1. Survey participant characteristics
Characteristic n %
Total survey participants 488 -
Category of Respondent
Lay persons 335 69%
Person with CF 194 (58%)
A parent of a child or
children with CF
130 (39%)
Spouse or partner of a
person with CF
2 (1%)
Other relative or friend










Respiratory Physician 5 3%
Pharmacist 2 1%
Exercise therapist 2 1%








North America 134 27%
Europe (non UK) 19 4%
Australia and New Zealand 7 1%
South America 1 -
Asia 1 -
Africa 1 -
Participant location unknown 105 22%
Age of survey participants
Median age (all participants), years
(range)
37 (14-74)
Median age of respondents with CF or
those answering on their behalf, years
(range)
15.5 (1-74)
Median age of respondents with CF
(range)
33 (14-74)
Median age of people with CF whose
parents or family answered on their
behalf, years (range)
8 (1-33)







Walking 91 34% 3.5
Run 86 32% 8
Swim 59 22% 8
Bike 53 20% 8
Team sports 48 18.% 8
Strength training 46 17% 8
Gym 40 15% 5.5
Trampolining 33 12% 4.5
Dance 31 12% 6.5
Yoga 26 10% 2.5
Gymnastics 19 7% 4
Martial Art 10 4% 10
HIIT 9 3% 8
Cross Fit 8 3% 8
Exercise Class 8 3% 6.5
Pilates 8 3% 3.5
Climbing 5 2% 11
Horse riding 4 2% 4
Rowing 4 2% 7
Skiing 4 2% 7
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